Literature DB >> 3894763

Transplant glomerulopathy: evolution of morphologically distinct changes.

R K Maryniak, M R First, M A Weiss.   

Abstract

The study was undertaken to redefine morphological appearance and clinical implications of the diagnosis of transplant glomerulopathy (TGP). Fifty-seven renal transplant biopsy specimens from thirty patients with the diagnosis of TGP were evaluated. Multiple repeat biopsies in several cases enabled us to follow the pattern of the evolution of the changes. Transplant dysfunction manifested itself 8 days to 13 years post-transplantation by proteinuria and/or elevated creatinine level. The earliest recognizable morphological change was the swelling of endothelial and mesangial cells. This stage was called evolving TGP. The intermediate stage was characterized by enlarged glomeruli with lobular simplification, spongy matrix, and glomerular basement membrane (GBM) deformities. The advanced stage of TGP showed pronounced GBM changes (reduplication, interposition). These light microscopic changes were associated with vascular rejection. Immunofluorescence showed significant glomerular deposition of IgM (83% of biopsies) and fibrinogen (66%). Electron microscopy at an early stage showed subendothelial widening with cellular debris and focal endothelial damage with fibrin deposition. In the advanced stage, complex GBM changes developed as a reparative response to the capillary wall injury. Effacement of foot processes was a constant finding at all stages. In follow-up, twenty-three allografts failed (77%), five patients are stable, and two died due to other causes. TGP has specific morphology with an attendant poor long-term prognosis for the allograft.

Entities:  

Mesh:

Year:  1985        PMID: 3894763     DOI: 10.1038/ki.1985.83

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  18 in total

1.  Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.

Authors:  Simone A Joosten; Mieneke G A van Dixhoorn; Maria C Borrias; Hallgrimur Benediktsson; Peter A van Veelen; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Mononuclear cells in acute allograft glomerulopathy.

Authors:  T V Tuazon; E E Schneeberger; A K Bhan; R T McCluskey; A B Cosimi; R T Schooley; R H Rubin; R B Colvin
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

Review 3.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

4.  The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics.

Authors:  Tara K Sigdel; Nathan Salomonis; Carrie D Nicora; Soyoung Ryu; Jintang He; Van Dinh; Daniel J Orton; Ronald J Moore; Szu-Chuan Hsieh; Hong Dai; Minh Thien-Vu; Wenzhong Xiao; Richard D Smith; Wei-Jun Qian; David G Camp; Minnie M Sarwal
Journal:  Mol Cell Proteomics       Date:  2013-12-12       Impact factor: 5.911

5.  Acute transplant glomerulopathy with monocyte rich infiltrate.

Authors:  Colin R Lenihan; Jane C Tan; Neeraja Kambham
Journal:  Transpl Immunol       Date:  2013-09-19       Impact factor: 1.708

6.  Chronic rejection of rat renal allograft. III. Ultrastructure of vascular and glomerular changes.

Authors:  A Yilmaz; S Yilmaz; T Paavonen; J Rapola; P Häyry
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

7.  Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies.

Authors:  P S Randhawa; T Starzl; H C Ramos; M A Nalesnik; J Demetris
Journal:  Am J Kidney Dis       Date:  1994-07       Impact factor: 8.860

8.  Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients.

Authors:  Shirley Chang; M Luiza Caramori; Rika Moriya; Michael Mauer
Journal:  Diabetes       Date:  2008-03-28       Impact factor: 9.461

Review 9.  Late kidney allograft loss: what we know about it, and what we can do about it.

Authors:  Anthony M Jevnikar; Roslyn B Mannon
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

Review 10.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.